Table 2.

Change from baseline to week 52 in effectiveness endpoints—ITT population (n = 49)

Endpoint	Mean (95%CI)	P value
WOMAC pain	− 17.7 (− 23.1; − 12.4)	< 0.0001
WOMAC stiffness	− 11.0 (− 17.0; − 4.9)	0.0007
WOMAC physical function	− 14.9 (− 19.1; − 10.6)	< 0.0001
Patient Global Assessment	− 16.3 (− 23.1; − 9.4)	< 0.0001